Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接仙碱治疗效果不明显转而接
氨苯砜治疗的患者应当继
服用
仙碱。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接仙碱治疗效果不明显转而接
氨苯砜治疗的患者应当继
服用
仙碱。
声明:以上例句、词性分类均由互联网资源自,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,内容亦不代
本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其达内容亦不代
软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开秋水仙碱治疗效果不明显转而
氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性类均由互联网资源自动生
,
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继服用秋水仙碱。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达
不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
,
么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审,
达内容亦不代
本软件的观点;若发现问题,欢迎向
们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件点;若发现问题,欢迎向我们指正。